• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD INLAY OPTIMA URETERAL STENT WITH HYDROGLIDE GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD INLAY OPTIMA URETERAL STENT WITH HYDROGLIDE GUIDEWIRE Back to Search Results
Catalog Number 787624
Device Problem Material Fragmentation (1261)
Patient Problem Foreign Body In Patient (2687)
Event Date 09/23/2020
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.
 
Event Description
It was reported that the black tip part of the ureteral catheter got detached and remained in the patient kidney during the stent replacement.The doctor 's opinion was that the ureter was possibly compressed by a malignant tumor, but since the patient had experiences using the device, and that the ureter would not be that narrowed and there was no resistance.The black tip part of the ureteral catheter was confirmed in the kidney by computerized tomography (ct) but could not be removed immediately considering the patient's condition and needed an early response as the adhesion defect was suspected.Per follow up on (b)(6) 2020, the tip was confirmed to be remained in the kidney by computerized tomography (ct) but could not be removed immediately considering the patient's condition.Not obtained additional information of removal of the tip.
 
Event Description
It was reported that the black tip part of the ureteral catheter got detached and remained in the patient kidney during the stent replacement.The doctor 's opinion was that the ureter was possibly compressed by a malignant tumor, but since the patient had experiences using the device, and that the ureter would not be that narrowed and there was no resistance.The black tip part of the ureteral catheter was confirmed in the kidney by computerized tomography (ct) but could not be removed immediately considering the patient's condition and needed an early response as the adhesion defect was suspected.Per follow up on (b)(6) 2020, the tip was confirmed to be remained in the kidney by computerized tomography (ct) but could not be removed immediately considering the patient's condition.Not obtained additional information of removal of the tip.
 
Manufacturer Narrative
The reported event was confirmed as supplier related issue.Evaluation found breakage at the tip of the tigertail.However, the broken tip was not returned for evaluation.The reported event which is related to material fragmentation is considered as part of defective component issue.The potential root cause for this failure mode could be, ¿defects component from supplier¿.The device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use were found adequate and state the following: "precautions for use ureteral catheter (1) when using the tigertailtm ureteral catheter, especially without the stabilizing support of a guidewire, be aware that a malfunction may occur where the flexible tip may detach if excessive force is made in contact with the walls of the bladder, ureter or renal pelvis.Should the flexible tip portion of the catheter become detached, retrieve with an endourology grasping device.(2) do not withdraw the ureteral catheter while it is deflected in endoscope.(3) avoid sharp bending of the ureteral catheter.(4) when performing drainage of urine, retrograde visualizations etc.Though the ureteral catheter, attach the ureteral catheter adapter to the tip of ureteral catheter.(5) do not over-tighten the catheter adapter.Over-tightening of the catheter adapter may occlude the lumen of the catheter.(2) ureteroarterial fistula may be formed between the ureter and the aorta of the iliac artery and result in massive hemorrhage at the replacement of the ureteral stent if a ureteral stent is placed for a long term in a patient who has undergone the intrapelvic surgery or irradiation.Therefore, carefully monitor the condition of the patient, and in the event of acknowledging bleeding from the urethra, perform retrograde pyelography or angiography, and provide appropriate care." correction: b.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : the actual/suspected device was inspected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD INLAY OPTIMA URETERAL STENT WITH HYDROGLIDE GUIDEWIRE
Type of Device
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
MDR Report Key10711458
MDR Text Key212299657
Report Number1018233-2020-20267
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
PMA/PMN Number
K043193
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 11/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/21/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/28/2023
Device Catalogue Number787624
Device Lot NumberMYER0117
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/06/2020
Date Manufacturer Received12/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-